Humana Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Humana Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
3.7×Over the last 3 years its own operating cash covered its investment spending (capex) 3.7 times.
Higher than 82% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$4Sales grew 40% in 3 years, but profit fell: $4 less profit per $100 of extra sales.
Lower than 71% of Healthcare companies in United States.
Asset Productivity Ratio
+40% / +14%In 3 years sales changed by +40% while total assets changed by +14%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
No debt dueNo debt falls due within a year, according to the latest yearly balance sheet.
Cash Cushion Ratio
+15%Cash, after subtracting all debt, equals 15% of its market value (net cash).
Higher than 57% of Healthcare companies in United States.
Tangible Assets Ratio
78%Of every $100 the company owns, $78 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 54% of Healthcare companies in United States.
Tangible Net Worth Ratio
39%Of every $100 of net worth, $39 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 59% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Humana Inc. owes $0.66 for every $1 it owns. Net profit fell 2% in the year to Dec 2025, and shrank 25% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
39.8Investors pay $39.8 for every $1 of Humana Inc.'s yearly profit, higher than 72% of Healthcare companies in United States.
P/B ratio
2.63The share price is 2.63 times Humana Inc.'s book value per share, higher than 51% of Healthcare companies in United States.
Market cap
$50.6 BThe total market value of all of Humana Inc.'s shares at today's price (share price × number of shares), larger than 96% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$19.2 BWhat Humana Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$160.00Net worth divided by the number of shares. The share price of $420.97 is 2.6 times this, which is the P/B above.
Return on equity (ROE)
6.9%Humana Inc. earned 6.9% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.
Owes vs Owns
0.66×Humana Inc. owes $0.66 for every $1 it owns (moderate), higher than 69% of Healthcare companies in United States.
Dividend yield
0.83%Humana Inc. pays 0.83% of its share price as dividends a year, lower than 59% of dividend-paying Healthcare companies in United States.
Revenue growth
+10%Revenue rose 10% in the year to Dec 2025, and grew 12% a year on average over 3 years.
Profit growth
-2%Net profit fell 2% in the year to Dec 2025, and shrank 25% a year on average over 3 years.
Profit margin
0.9%Humana Inc. keeps $1 of every $100 of revenue as net profit.
Cash quality
0.8×Cash from Humana Inc.'s business was 0.8× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.
Cash vs debt
Net cashHumana Inc. held $7.5 B more cash than debt (net cash) at Dec 2025.
Questions
What is Humana Inc.'s P/E ratio?
Investors pay $39.8 for every $1 of Humana Inc.'s yearly profit, higher than 72% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Humana Inc.: $50.6 B ÷ $19.2 B (30 Jun 2026) = 2.6.
What is Humana Inc.'s return on equity?
Humana Inc. earned 6.9% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.
How much does Humana Inc. owe compared with what it owns?
Humana Inc. owes $0.66 for every $1 it owns (moderate), higher than 69% of Healthcare companies in United States.
Does Humana Inc. pay a dividend?
Yes. Humana Inc. pays 0.83% of its share price as dividends a year, lower than 59% of dividend-paying Healthcare companies in United States.
Is Humana Inc.'s revenue growing?
Revenue rose 10% in the year to Dec 2025, and grew 12% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.